Levent Ündar

6PUBLICATIONS
128CO-AUTHORS
Haematological tumoursPredictive and prognostic markersFood properties (incl. characteristics and health benefits)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 27, 2026
JC Virus Reactivation Should Be Considered in Late Neurotoxicity Associated with Bispecific Antibody Therapy: A Comment. Comment on Bangolo et al. Comprehensive Review of Early and Late Toxicities in CAR T-Cell Therapy and Bispecific Antibody Treatments for Hematologic Malignancies. Cancers 2025, 17, 282.

|Oct 29, 2025
Real-World Outcomes of Antifungal Prophylaxis in Adult Acute Lymphoblastic Leukemia Patients: A Multicenter Comparison of the Use of Fluconazole and Micafungin.

Unal Atas, Utku Iltar, Orhan Kemal Yucel

|Nov 06, 2024
Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents: A Real-Life Multicenter Analysis

Ünal Ataş, Ozan Salim, Utku Iltar

|Nov 07, 2022
The Prognostic Impact of Pretreatment Geriatric Nutritional Risk Index in Patients with Diffuse Large B-Cell Lymphoma.

Unal Atas, Hasan Sozel, Utku Iltar

|Jul 23, 2019
A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience

Demet Çekdemir, Serkan Güvenç, Füsun Özdemirkıran

Pageof 1

Frequent Collaborators

4 joint publications

Utku Iltar

4 joint publications

Unal Atas

3 joint publications

Orhan Kemal Yücel

3 joint publications

Ozan Salim